Novabase is
a Portuguese Information Technologies company. Up until now their business included
three divisions: business services (BS); infrastructure managed services (IMS) and
venture capital. As we will see, venture capital is a very small component of
the company and they have just sold the IMS division. So what did they sell and
keep?
EBITDA IMS:
2011: 7,7 M
2012: 6,3 M
2013: 4,1 M
2014: 4,6 M
2015: 2,9 M
5yr average:
5,1; 3yr average: 3.9; Median: 4,6
EBITDA Business
Solutions:
2011: 10,9
M
2012: 12,7
M
2013: 11,2
M
2014: 8,6 M
2015: 11,5
M
5yraverage:
11.0; 3yraverage: 10.4; Median: 11,2
EBITDA Venture capital 2015:0,5M
So they
sold about somewhere between 20% and 40% of the business. The sale value
initially was 38,365M, subject to adjustments, but was concluded this month by
44,0M (subject to final working capital and net debt adjustments). So
basically, it seems they sold IMS for a 44,0M enterprise value (9,6x median EBITDA)
.
In June
2016, they had 8,2M net cash. In the last 6 months of 2015 they generated 4,9M
net cash. If we assume they did the same in the 2nd half 2016, then present
net cash is: 8,2+4,9+44= 57,1M (or 1,82€/share).
Estimated
present position:
If I am
right, Novabase now consists in:
57,1M in net
cash
A 11,5M
EBITDA business
A small venture
capital business (0,5M EBITDA in 2015)
And what
does the market say?
Market cap
(at 2,677): 84 M
Enterprise
value (estimated): 26,9 M
What will
they do with the money? – part one
Historically:
At the end
of 2012 they had 37,5M (1,19€/share) net cash (up from 14,7M in 2011). They distributed 0,8 €/share (25,1M
) in two year’s time and ended 2014 with 6,9M net cash. This means they consumed
5,5M cash in those two years despite having sold (net of cash and acquisitions)
businesses worth 4,25M (so they consumed 9,75M). It is important to note that a good part of net cash generated in 2012 was likely the result of a reduction in working
capital, which was reversed in the following two years (and there were
restructuring costs in 2014).
What they
say:
“This is
another step towards Novabase’s repositioning that has been carried out in the
past few years, allowing us to accelerate internationalization with stronger
means.”
Going back
to previous reports:
“Novabase
has defined as a priority for 2016 the continuity of the strategic focus on
internationalization, adjusting the focus on the risks of the current global
macroeconomic situation. Therefore, Novabase will limit its exposure to
emerging markets, given the volatility in some of the economies where it
operates.” – 2015 Annual report
“Novabase
has defined as a priority for 2016 the continuity of the strategic focus on
internationalization, adjusting the focus on the risks of the current global
macroeconomic situation. Therefore, Novabase will limit its exposure to
emerging markets, given the volatility in some of the economies where it
operates.
“as a
result of discontinuation of some offers that added lower value and our policy
to limit the exposure to emerging markets Turnover and EBITDA decreased BY 6%
and 7%, respectively”– 6months 2016 report.
This means
they have been holding back in 2016. Despite that, business solutions
international sales were 41% in 2014 and 60% in 1H2016. It is reasonable to
expect that some of the cash from the sale will be reinvested. However, since
60% of total sales are already international, it is likely that most of the
investment is already in place, and as such this investment might have an
higher impact in profits than previous investments (probably mostly working
capital investment).
What will
they do with the money? – part two – what do I expect?
This time the increase in net cash is due to completely different causes than in 2012 and as such I would expect that:
a) Any working capital investment is growth investment (instead of just going back to normal levels)
b) Distributable cash is higher (in % of net cash), because growth investment is already taken care of;
Most likely
they will distribute most cash as dividends (maybe 1€/share), reinvest about
20M and still keep almost 6M in net cash (they have always kept net cash so it
would be foul to assume they would change to a more balanced net position). The
20M reinvestment should be enough (or more than enough) for substituting IMS
EBITDA and keep profits levels, while allowing room for an higher payout of
future earnings.
What valuation
do I get to?
31,5M
dividend plus a 15M EBITDA business with 6M net cash. At 7 times EBITDA (which
seems a conservative multiple) that would mean a 142,5M (4,54€/share). At 5
times EBITDA it would mean 112.5M (3,58€/share ). Any
cash generated in the meantime should be added to returns since I expect an higher
payout ratio.
Disclaimer:
I own shares of Novabase. This is not an investment advice and I am not a
professional adviser. Always do your own research. I am and will be wrong about
many things, it is possible that this is one of those. Always read the introduction post.